Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, et al. Thalassemia, a human blood disorder. Braz J Biol. 2021;83:e247362. https://doi.org/10.1590/1519-6984.247362.
Unissa R, Monica B, Konakanchi S, Darak R, Keerthana SL, Kumar SA. Thalassemia: a review. Asian J Pharm Res. 2018;8(3):195–202. https://doi.org/10.5958/2231-5691.2018.00034.5.
AlMosawi R, Al-Rashedi N, Ayoub N. Clinical laboratory manifestation and molecular diagnosis of β-thalassemia patients in Iraq. J Pediatr Hematol Oncol. 2020;42(1):27–31. https://doi.org/10.1097/MPH.0000000000001656.
Article PubMed CAS Google Scholar
El-Beshlawy A, Rabah F, Hamed H, Mahmoud A, Hanan A, Abdelhamid E, et al. Navigating hemostasis of bleeding among children with β-thalassemia. J Pediatr Hematol Oncol. 2022;44(4):e855–8. https://doi.org/10.1097/MPH.0000000000002391.
Article PubMed CAS Google Scholar
Nithichanon A, Tussakhon I, Samer W, Kewcharoenwong C, Ato M, Bancroft GJ, et al. Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes. Sci Rep. 2020;10(1):10297. https://doi.org/10.1038/s41598-020-67346-2.
Article PubMed PubMed Central CAS Google Scholar
Rivella S. Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia. Blood. 2019;133(1):51–8. https://doi.org/10.1182/blood-2018-07-815928.
Article PubMed PubMed Central CAS Google Scholar
Babker A. An overview on thalassemia and challenges during COVID-19. Int J Health Sci (Qassim). 2022;6(S1):3207–20. https://doi.org/10.53730/ijhs.v6nS1.5446.
Ehrenschwender M, Wajant H. The role of FasL and Fas in health and disease. In: Therapeutic targets of the TNF superfamily. New York: Springer; 2009. pp. 64–93. https://doi.org/10.1007/978-0-387-89520-8_5
Raducka-Jaszul O, Bogusławska DM, Jędruchniewicz N, Sikorski AF. Role of extrinsic apoptotic signalling pathway during definitive erythropoiesis in normal patients and in patients with β-thalassemia. Int J Mol Sci. 2020;21(9):3325. https://doi.org/10.3390/ijms21093325.
Article PubMed PubMed Central CAS Google Scholar
Ribeil JA, Arlet JB, Dussiot M, Cruz Moura I, Courtois G, Hermine O. Ineffective erythropoiesis in β-thalassemia. Sci World J. 2013;2013:394295. https://doi.org/10.1155/2013/394295.
Wang M, Su P. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: an update. Syst Biol Reprod Med. 2018;64(2):93–102. https://doi.org/10.1080/19396368.2017.1422046.
Article PubMed CAS Google Scholar
Lai TY, Cao J, Ou-Yang P, Tsai CY, Lin CW, Chen CC, et al. Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand. Sci Rep. 2022;12(1):5713. https://doi.org/10.1038/s41598-022-09605-y.
Article PubMed PubMed Central CAS Google Scholar
Jabir FA, Hoidy WH. Pharmacogenetics as personalized medicine: association investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 polymorphisms in a breast cancer population in Iraqi women. Clin Breast Cancer. 2018;18(5):e863–8. https://doi.org/10.1016/j.clbc.2018.01.009.
Article PubMed CAS Google Scholar
Zhang DF, Jiang GB, Qin CQ, Liu DX, Hu YJ, Zhou J, et al. Quantitative assessment of the relationship between Fas/FasL genes polymorphisms and head and neck cancer risk. Medicine (Baltimore). 2018;97(6):e9873. https://doi.org/10.1097/MD.0000000000009873.
Article PubMed CAS Google Scholar
Rieux-Laucat F, Magérus-Chatinet A, Neven B. The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions. J Clin Immunol. 2018;38:558–68. https://doi.org/10.1007/s10875-018-0523-x.
Article PubMed CAS Google Scholar
Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017;86:715–48. https://doi.org/10.1146/annurev-biochem-061516-045037.
Article PubMed CAS Google Scholar
Gharehdaghi Z, Yasuj S. Hematological and biochemical parameters of β-thalassemia major patients in Bushehr City: a comparative analysis. Int J Med Lab. 2023;10(1):57–66. https://doi.org/10.18502/ijml.v10i1.12426.
Hoidy W, Essa S, Al-Saadi M. Association of the manganese superoxide dismutase (Mn-SOD) gene C47T polymorphism with lung cancer: a case–control study. Asian Pac J Cancer Prev. 2022;23(8):2617–23. https://doi.org/10.31557/APJCP.2022.23.8.2617.
Article PubMed PubMed Central CAS Google Scholar
Hoidy WH, Nubgan A, Al-Saadi MH. Development of a T-ARMS-PCR assay for detecting genetic polymorphism in the catalase (rs7943316) gene in the Iraqi population with breast cancer. Asian Pac J Cancer Prev. 2023;24(9):3283–9. https://doi.org/10.31557/APJCP.2023.24.9.3283.
Article PubMed PubMed Central CAS Google Scholar
Bissinger R, Bhuyan A, Qadri S, Lang F. Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases. FEBS J. 2019;286(5):826–54. https://doi.org/10.1111/febs.14606.
Article PubMed CAS Google Scholar
Fibach E, Dana M. Oxidative stress in β-thalassemia. Mol Diagn Ther. 2019;23(2):245–61. https://doi.org/10.1007/s40291-018-0373-5.
Article PubMed CAS Google Scholar
Islam MN, Rauf A, Fowzul F, Emran TB, Mitra S, Olatunde A, et al. Superoxide dismutase: an updated review on its health benefits and industrial applications. Crit Rev Food Sci Nutr. 2022;62(26):7282–300. https://doi.org/10.1080/10408398.2021.1913400.
Kockum I, Huang J, Stridh P. Overview of genotyping technologies and methods. Curr Protoc. 2023;3(4): e727. https://doi.org/10.1002/cpz1.727.
Article PubMed CAS Google Scholar
Matsuda K. PCR-based detection methods for single-nucleotide polymorphism or mutation: real-time PCR and its substantial contribution toward technological refinement. Adv Clin Chem. 2017;80:45–72. https://doi.org/10.1016/bs.acc.2016.11.002.
Article PubMed CAS Google Scholar
Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, Socolovsky M. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood. 2006;108(1):123–33. https://doi.org/10.1182/blood-2005-11-4458.
Article PubMed PubMed Central CAS Google Scholar
Alwan F. Hematological study of some blood parameters in patient with major β-thalassemia. Plant Arch. 2021;21(1):1435–7. https://doi.org/10.51470/plantarchives.2021.v21.s1.224.
Baghersalimi A, Rad A, Koohmanaee S, Darbandi B, Mirzaee M, Aminzadeh V, et al. The cut-off of ferritin for evaluation of hypothyroidism in patients with thalassemia. J Pediatr Hematol Oncol. 2019;41(7):515–8. https://doi.org/10.1097/MPH.0000000000001489.
Article PubMed CAS Google Scholar
Salih MM, Al-Ziaydi AG, Alzamili AHH. The effect of Ferritin level and gene expression of β-globin promoter with β-thalassemia patients in Al-Qadisiyah Governorate, Iraq. J Appl Hematol. 2023;14(4):257–62. https://doi.org/10.4103/joah.joah_98_23.
Belhoul K, Bakir M, Saned M, Kadhim A, Musallam K, Taher A. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol. 2012;91:1107–14. https://doi.org/10.1007/s00277-012-1412-7.
Comments (0)